Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bacterial vaginosis.

C H Weaver1, M B Mengel

  • 1Department of Family Medicine, University of Washington, School of Medicine, Seattle.

The Journal of Family Practice
|August 1, 1988
PubMed
Summary
This summary is machine-generated.

Bacterial vaginosis (BV) is a vaginal infection linked to increased anaerobic bacteria and decreased lactobacilli. Diagnosis relies on clinical signs, not symptoms, and Gram stain confirms cure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Keely Treatment.

The Dental register·2021
Same author

The Rationale for not Routinely Purging Autologous Blood Stem Cell Grafts.

Hematology (Amsterdam, Netherlands)·2016
Same author

Herpes zoster in patients with bullous pemphigoid: a population-based case-control and cohort study.

The British journal of dermatology·2015
Same author

Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cells.

Cytotherapy·2002
Same author

Economic evaluation of filgrastim, sargramostim, and sequential sargramostim and filgrastim after myelosuppressive chemotherapy.

Bone marrow transplantation·2002
Same author

Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.

Bone marrow transplantation·2001
Same journal

Does taking BP medicine at night (vs morning) result in fewer cardiovascular events?

The Journal of family practice·2023
Same journal

Preventing RSV in children and adults: A vaccine update.

The Journal of family practice·2023
Same journal

Essential oils: How safe? How effective?

The Journal of family practice·2023
Same journal

51-year-old woman • History of Graves disease • General fatigue, palpitations, and hand tremors • Dx?

The Journal of family practice·2023
Same journal

Renewing the dream.

The Journal of family practice·2023
Same journal

55-year-old woman • Myalgias and progressive symmetrical proximal weakness • History of unilateral renal agenesis, type 2 diabetes, and hyperlipidemia • Dx?

The Journal of family practice·2023
See all related articles

Area of Science:

  • Gynecology
  • Microbiology
  • Infectious Diseases

Background:

  • Bacterial vaginosis (BV), or nonspecific vaginitis, is a common vaginal infection characterized by an overgrowth of anaerobic organisms and a reduction in protective lactobacilli.
  • While Gardnerella vaginalis was once considered the primary cause, BV is now understood to involve an imbalance of endogenous vaginal flora.
  • Risk factors include Trichomonas infections, increased sexual activity, and intrauterine device (IUD) use, and BV is associated with adverse outcomes in pregnant women.

Purpose of the Study:

  • To review the current understanding of bacterial vaginosis (BV) etiology, risk factors, diagnosis, and treatment.
  • To highlight the importance of clinical signs and Gram stain for accurate diagnosis and cure assessment.
  • To discuss the role of metronidazole and the potential benefit of treating male sexual partners.

Related Experiment Videos

Main Methods:

  • Review of epidemiological studies and clinical research on bacterial vaginosis.
  • Analysis of diagnostic criteria, including clinical signs versus subjective symptoms.
  • Evaluation of treatment efficacy, including metronidazole regimens and partner treatment.

Main Results:

  • Symptoms are unreliable for diagnosing BV; clinical signs offer better diagnostic accuracy.
  • Gram stain is the preferred method for assessing treatment cure, outperforming clinical criteria.
  • Metronidazole is the established treatment of choice, with a single-dose option available.
  • Evidence suggests treating male sexual partners may be effective, but further research is needed for a general recommendation.

Conclusions:

  • Accurate diagnosis of BV relies on clinical assessment and Gram stain for cure verification.
  • Metronidazole remains the primary treatment, with dosage flexibility based on patient factors.
  • The role of male sexual partner treatment requires further investigation before widespread adoption.